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Malaria is a worldwide health problem leading the death of millions of people. The disease
is induced by different species of protozoa parasites from the genus Plasmodium. In
humans, Plasmodium falciparum is the most dangerous species responsible for severe
disease. Despite all efforts to establish the pathogenesis of malaria, it is far from being fully
understood. In addition, resistance to existing drugs has developed in several strains and
the development of new effective compounds to fight these parasites is a major issue.
Recent discoveries indicate the potential role of the renin-angiotensin system (RAS) in
malaria infection. Angiotensin receptors have not been described in the parasite genome,
however several reports in the literature suggest a direct effect of angiotensin-derived
peptides on different aspects of the host-parasite interaction. The aim of this review is to
highlight new findings on the involvement of the RAS in parasite development and in the
regulation of the host immune response in an attempt to expand our knowledge of the
pathogenesis of this disease.
Keywords: malaria, invasion, erythrocytes, renin-angiotensin system, immune response, host-cell interaction,
T cells, Plasmodium falciparum
INTRODUCTION
Malaria is a serious public health problem. The most severe form of the disease is related
to Plasmodium falciparum, which is responsible for many deaths every year (World Health
Organization, 2014). High parasitemia along with an impaired immune response are important
elements responsible for the severity and lethality of the disease (Schofield and Grau, 2005).
Malaria-associated symptoms appear during the blood stage of the disease with infection
of erythrocytes. Erythrocyte invasion by Plasmodium has always been credited to parasitic
mechanisms and host-cell participation regarded as passive. However, new findings highlight the
importance of host-specific signaling pathways that can control parasite invasion and development
(Harrison et al., 2003; Murphy et al., 2006; Saraiva et al., 2011).
In this context, a multi-center study, based on genetic epidemiology, proposed an association
between the occurrence of single nucleotide polymorphisms in the gene encoding the G alpha-S
subunit and individual susceptibility to severe malaria, demonstrating that G-protein coupled
receptor (GPCR) signaling in the host has an influence at the disease level (Auburn et al., 2008,
2010).
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The renin-angiotensin system (RAS) is a proteolytic cascade
that generates peptides that bind and signal through GPCRs.
Classically, this system is involved in the regulation of
intravascular volume and systemic blood pressure, acting in the
renal and cardiovascular systems. In this peptidergic system,
angiotensin II (Ang II) is formed from the enzymatic cleavage
of angiotensinogen to angiotensin I (Ang I) by aspartyl
protease renin, with subsequent conversion to Ang II by
angiotensin-converting enzyme (ACE) (Mizuiri and Ohashi,
2015). Angiotensin-converting enzyme 2 (ACE2), a homolog
carboxypeptidase of ACE can convert Ang II into angiotensin-
(1–7) [Ang-(1–7)] or counter-regulate ACE activity competing
for the same substrate, Ang I. Through cleavage of Ang I, ACE2
produces Ang-(1–9), which is converted to Ang-(1–7) by ACE
(Ferrario, 2006). Therefore, the balance between ACE and ACE2
could determinate the levels of Ang II and Ang-(1–7).
Ang II exerts its actions via AT1 and AT2 receptors,
which in principle, mediate opposite functions. AT1 receptors
promote vasoconstriction, thirst and release of vasopressin and
aldosterone, fibrosis, cellular growth, and migration (Fyhrquist
and Saijonmaa, 2008). On the other hand, AT2 receptor
stimulation leads to vasodilation, release of nitric oxide (NO),
natriuresis, and inhibition of growth (Fyhrquist and Saijonmaa,
2008). Furthermore, the activity of both receptors may be altered
by oligomerization, association with various interacting proteins,
or ligand-independent effects (Villela et al., 2015).
Ang-(1–7) has its actions mediated specifically by the
MAS receptor, inducing vasodilation by amplifying the effects
of bradykinin, stimulating cGMP synthesis, and inhibiting
the release of norepinephrine (Ferrario, 2006). Moreover,
alamandine, another active hormone formed via decarboxylation
of the aspartate radical group of Ang-(1–7), binds to the Mas-
related receptor MrgD and has similar effects to Ang-(1–7)
(Lautner et al., 2013). In this regard, ACE 2, Ang (1–7) and
MAS receptors play a role counter-balancing excess activity of the
Ang II/AT1 axis (Danilczyk and Penninger, 2006; Der Sarkissian
et al., 2006). The expression and activity of ACE2 is upregulated
by treatment with ACE inhibitors, such as captopril, promoting
increased local production of Ang (1–7) (Ferrario, 2005; Ferrario
et al., 2005).
The discovery of new RAS components and different local
production has shifted attention to its non-classic effects. Here,
we review recent findings that correlate local and systemic
RAS with the host-parasite interaction in different levels of
response. This could open new avenues in the elucidation of
the molecular mechanisms involved in the pathogenesis of
malaria.
THE ROLE OF RAS IN ERYTHROCYTE
INVASION
Evidence in the literature showing that angiotensin II (Ang
II) and related peptides impair parasite development were first
demonstrated in the sexual cycle of P. galinacium, an avian
malaria parasite (Maciel et al., 2008). The authors postulated that
Ang II reduces the accumulation of sporozoites in the salivary
gland of the mosquito vector by directly disturbing the parasite
membrane. However, this effect seems to occur in a receptor-
independent manner.
Other studies have reported an apparent protective effect of
Ang II in malaria. A genetic association study was carried out in
Orissa, India, to search for a possible influence of polymorphisms
in angiotensin I-converting enzyme (ACE) and angiotensin II-
converting enzyme (ACE2) on the outcome of malaria. It was
shown that the D allele of ACE I/D polymorphism, which
increases Ang II production, is associated with mild malaria.
ACE2 C→T substitution, a polymorphism that reduces ACE2
expression in the presence of the T allele also results in an
increase in Ang II, by reducing its conversion to Ang-(1–7)
(Dhangadamajhi et al., 2010). Further evidence that ACE and
ACE2 polymorphisms and consequent increased plasma levels
of Ang II are associated with malaria severity was demonstrated
in people with an African genetic background (Gallego-
Delgado and Rodriguez, 2014). In this population, it seems
that these polymorphisms confer protection from severe malaria
in childhood but deleterious effects, such as hypertension, in
adulthood (Gallego-Delgado and Rodriguez, 2014). Thus, it was
suggested that higher levels of Ang II protect against cerebral
malaria. However, the molecular mechanism involved in disease
protection was not shown.
Our group was the first to further characterize the molecular
mechanisms involved in the anti-malarial effects of angiotensin
peptides during the blood stage of P. falciparum (Saraiva et al.,
2011). In accordance with previous studies, we found that Ang II
decreased the invasion of human erythrocytes by P. falciparum
in a dose-dependent manner. Even though Ang II receptors,
AT1 and AT2, were demonstrated in the erythrocyte membrane,
surprisingly, this effect was not mediated by these receptors.
This evidence suggested the metabolism of Ang II and the
generation of other biologically active peptides. Mas receptor
expression in the erythrocyte membrane and its ligand, Ang-(1–
7), in the culture supernatant were detected. Ang-(1–7) reduced
erythrocyte invasion by the samemagnitude as Ang II. This effect
was sensitive to A779, a Mas antagonist and not blocked by
Losartan, an AT1 receptor antagonist.
In erythrocytes, the increase in cAMP levels and consequent
PKA activation improve erythrocyte invasion by P. falciparum
(Harrison et al., 2003). Accordingly, cAMP analog increases
erythrocyte invasion in vitro, whereas PKA inhibitor reduces
it and reverses the stimulation induced by the cAMP analog.
Moreover, PKA activity is reduced in the presence of Ang-(1–7)
in a Mas-dependent manner (Saraiva et al., 2011). Our data
suggest that Ang II is metabolized to Ang-(1–7), which binds
specifically to the Mas receptor, decreasing PKA activity and
consequently reducing parasite invasion (Figure 1).
Interestingly, (Gallego-Delgado et al., 2015) demonstrated a
significant reduction in blood parasitemia in mice infected with
Plasmodium berghei ANKA treated with a supraphysiological
concentration of Ang II. They also observed delayed
establishment of cerebral malaria and decreased incidence
of brain hemorrhage followed by a modest increase in survival.
Because Ang II is quickly degraded forming different peptides,
the improvement in the condition of mice could be attributed
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FIGURE 1 | Proposed model of the inhibitory effect of Ang-(1–7) during
P. falciparum invasion of human erythrocytes. 1, Ang II is converted to
Ang-(1–7) by ACE 2 activity; 2, Ang-(1–7) binds its specific receptor; Mas,
which is expressed in the human erythrocyte membrane; 3, a signaling
pathway is triggered inhibiting PKA activity; 4, decreased PKA activity impairs
merozoite invasion in the erythrocytes.
to increased levels of plasma Ang-(1–7), corroborating with our
evidence.
Because angiotensin peptides have biological effects on the
host, their use in anti-plasmodium therapy in vivo could
have some limitations. Recent studies have proposed structural
changes in RAS peptides, aiming to block their vascular and
renal effects without affecting the anti-plasmodial action (Maciel
et al., 2008; Chamlian et al., 2013; Silva et al., 2014, 2015).
Different angiotensin-restricted analogs have been synthesized
and tested for their anti-plasmodial effects on P. falciparum and
P. gallinaceum (Chamlian et al., 2013; Silva et al., 2014, 2015;
Torres et al., 2015) and some have been shown to have a potential
anti-plasmodial effect.
It is possible to assume that angiotensin peptides inhibit
the sexual and blood stage of avian as well as human
parasites. However, malaria is a multi-factorial disease and
as well as the increase in parasitaemia, other parasite-host
interactions are important in the pathogenesis of the disease. The
syndrome is marked by intense inflammatory immune responses,
sequestration of leukocytes, and parasitized erythrocytes in the
microvasculature. Involvement of angiotensin peptides in the
regulation of immune system has been suggested (Iwai et al.,
1996; Nataraj et al., 1999; Bush et al., 2000; Jurewicz et al., 2007;
Hoch et al., 2008; Geara et al., 2009; Silva-Filho et al., 2011, 2013,
2015). In the following, the role of RAS in the modulation of
T-cell responses during infection is reviewed.
T-CELL REGULATION BY THE ANG II/AT1
RECEPTOR AXIS IN MALARIA
In recent years, Ang II has been found to be a pro-inflammatory
molecule and pro-fibrotic agent, inducing ROS production, cell
growth, apoptosis, cell migration, and differentiation, which
contribute to progressive damage to organ function in disease
(Iwai et al., 1996; Nataraj et al., 1999; Bush et al., 2000; Donadelli
et al., 2000; Ruster and Wolf, 2006; Guzik et al., 2007; Jurewicz
et al., 2007; Hoch et al., 2008; Geara et al., 2009; Silva-Filho et al.,
2011, 2013, 2015).
With regard to lymphoid tissue, our group and others have
described the expression of all RAS components in T cells
(Nataraj et al., 1999; Jurewicz et al., 2007; Hoch et al., 2008;
Silva-Filho et al., 2011, 2013, 2015). T cells possess the necessary
enzymatic machinery to convert angiotensinogen substrate to
active Ang II in sufficient quantities to induce cellular autocrine
and/or paracrine effects, pointing out Ang II as a co-stimulatory
molecule for T-cell functions, such as activation, migration,
differentiation, and cytokine production (Nataraj et al., 1999;
Jurewicz et al., 2007; Hoch et al., 2008; Silva-Filho et al., 2011,
2013, 2015). Ang II levels produced by T cells seem to be
subtype and tissue specific, because CD4+ T cells produce higher
amounts of Ang II than CD8+ T cells and blood-derived T
cells produce more Ang II than cells harvested from the spleen
(Jurewicz et al., 2007; Hoch et al., 2008). Similarly, CD4+ T
cells express slightly higher levels of AT1 receptor compared
with CD8+ T cells, whereas AT2 receptor was barely detected
in these cells either on the surface or intracellularly (Jurewicz
et al., 2007; Hoch et al., 2008). In addition, activated T cells,
in vitro by anti-CD3 or in vivo by Plasmodium antigens, showed
upregulated AT1R expression while AT2R expression was not
changed (Silva-Filho et al., 2011, 2013).
An experimental model with P. berghei ANKA has been a
useful tool to understand the pathogenesis of malaria, including
cerebral malaria, one of the most severe clinical forms of P.
falciparum infection. Using murine infection, this model is well
validated to mimic human disease in some key pathologic aspects
(Schofield and Grau, 2005). Different effector cells such as CD4+
T cells, CD8+ T cells, natural killer T cells, and natural killer
cells also contribute to the pathogenesis of the disease (Yañez
et al., 1996; Belnoue et al., 2002; Hansen et al., 2003; Schofield
and Grau, 2005; Nie et al., 2009; Ohayon et al., 2010). However,
T cells are the one of the most important effector cells involved
in the syndrome after infection with P. berghei (Yañez et al., 1996;
Belnoue et al., 2002; Schofield and Grau, 2005; Nie et al., 2009;
Ohayon et al., 2010), because intravascular infiltration of T cells
in the brain vasculature during infection could be associated with
a local inflammatory response, determining the severity of the
disease (Yañez et al., 1996; Belnoue et al., 2002; Hansen et al.,
2003; Schofield and Grau, 2005; Schofield, 2007; Nie et al., 2009;
Ohayon et al., 2010). Thus, the signals and consequently the
cellular and molecular mechanisms regulating the T-cell immune
response are crucial to understand the role of these cells during
infection.
So far, the effect of Ang II and its receptors on T cells has
been well described using in vitro systems and in vivo models,
most of them exploring renal or cardiovascular diseases, but it
is not clear how RAS components influence the T-cell response
during parasitic diseases. In this regard, we found that Ang
II, via the AT1 receptor, was an important mediator for T-cell
activation, migration and adhesion during P. berghei ANKA
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infection in mice (Silva-Filho et al., 2013). We showed that the
RAS could be involved in the pathogenesis of not only non-
infectious diseases but also parasitic disease. Our results observed
in adhesion/migration experiments with splenic T cells from
P. berghei ANKA-infected mice confirmed observations from
other studies (Figure 2) (Bush et al., 2000; Donadelli et al., 2000;
Jurewicz et al., 2007; Crowley et al., 2008; Silva-Filho et al., 2011,
2013, 2015).
Endogenously produced Ang II induces T-cell adhesion in
endothelial cells and migration via the AT1 receptor (Figure 2;
Jurewicz et al., 2007; Silva-Filho et al., 2011, 2013, 2015).
As a possible cellular mechanism, Ang II upregulated LFA-1,
CCR2, and CCR5 expression in T cells (Figure 2). According
to previous observations (Crowley et al., 2008), Ang II also
induces cytoskeleton rearrangement and cell spreading, via the
AT1 receptor, when T cells are stimulated to adhere in vitro (Silva-
Filho et al., 2013). These results explain the role of Ang II/AT1
receptor in inducing T-cell adhesion/migration in vitro and
reduced sequestration of total CD3+ and CD8+ T lymphocytes
in the brain of mice infected with P. berghei ANKA when treated
with captopril, an ACE inhibitor (Figure 2) (Silva-Filho et al.,
2013). It seems that the Ang II/AT1 receptor axis drives activation
followed by sequestration of T lymphocytes in the brain of
infected animals (Silva-Filho et al., 2013).
In addition to decreased T-cell sequestration in the brain,
inhibition of Ang II/AT1 receptor signaling using losartan or
captopril in P. berghei ANKA-infected mice promoted some
survival benefits and attenuation of signals involved in the
development of cerebral malaria, such as cerebral oedema (Silva-
Filho et al., 2013). Reduced blood parasitaemia in treated mice
up to 5 days post infection was also observed. It is well known
that captopril increases the levels of Ang(1–7). As described
above, Ang(1–7) reduces P. falciparum invasion in vitro (Silva
et al., 2014). Similarly captopril-treated mice infected with P.
berghei ANKA showed lower parasitaemia than control mice
throughout the experiments (Silva-Filho et al., 2013). These
results corroborate the idea of GPCR agonists, such as Ang(1–
7), regulating parasite invasion (Saraiva et al., 2011). Therefore,
modulation of the activity of RAS components could be another
factor in the pathogenesis of malaria.
TARGETING RAS IS A POSSIBLE
THERAPEUTIC STRATEGY?
Together, these observations show that modulation of the activity
of RAS components could be considered as another factor in the
pathogenesis of malaria. The pharmacological approach used by
us and others initially aimed to prove the influence of RAS in
malaria pathogenesis and emerged as an interesting target in a
therapeutic strategy.
Although this matter is not clear, one could suggest that
the protective effect of Ang II on parasite invasion and
cerebral malaria seems to be a result of its conversion to
Ang (1–7) and its binding to MAS receptors. Our results,
schematically represented in Figures 1, 2, clearly indicate that
by promoting Ang II conversion to Ang (1–7) by captopril
treatment, Ang (1–7) stimulates MAS receptors on erythrocytes,
inhibiting PKA activity with a consequent decrease in parasite
invasion and growth (Figure 1). At same time, decreased AT1R
FIGURE 2 | Proposed model of Ang II effect on T cells during blood-stage of Plasmodium infection. Renin-Angiotensin System and Angiotensin receptors
are expressed by T cells. Endogenous Ang II could induce autocrine or paracrine effects, mediated by AT1R, which is upregulated during Plasmodium infection.
Different effects have been characterized, such as: activation, observed by upregulation of CD69 and CD25; adhesion/migration, mediated by upregulation of
chemokine receptors CCR2 and CCR5, adhesion molecule LFA-1 as well as rearrangements of actin cytoskeleton. Finally, Ang II, via AT1R, is also involved in T-cell
differentiation/effector function acquisition observed by increased production of cytokines IL-17 and IFN-γ, and perforin, a marker of cytotoxic activity.
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stimulation on T lymphocytes by blocking receptors with
losartan or by decreasing Ang II levels with captopril reduces the
exacerbated and harmful pro-inflammatory response mediated
by these cells (Figure 2). These effects on both parasitemia
and T-cell response seem to improve disease outcome. Indeed,
as discussed earlier, Silva-Filho et al. (2013) observed that
both captopril (an ACE inhibitor) and losartan (an AT1R
antagonist) treatments reduced parasitemia in mice infected
with P. berghei ANKA, probably by increasing Ang (1–7)
levels, and reduced T-cell activation, adhesion, migration, and
sequestration in the brain by inhibiting AT1R stimulation in these
cells.
Therefore, we could suggest that targeting RAS using agents
that promote the conversion of Ang II to Ang (1–7), favoringMas
signaling over AT1R signaling in erythrocytes and at same time
inhibiting AT1R stimulation in immune cells, is an interesting
approach to a potential therapeutic strategy.
CONCLUSIONS
The studies and results described in this review shed some light
on the functions and sources of RAS components. As already
observed in renal and cardiovascular diseases, unbalanced RAS
activity can also contribute to the pathogenesis of parasitic
infections via pathophysiologic actions. The work described
in this review may lead to new possibilities for therapeutic
interventions.
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